These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 15178309

  • 1. New 6-nitroquinolones: synthesis and antimicrobial activities.
    Sbardella G, Mai A, Artico M, Setzu MG, Poni G, La Colla P.
    Farmaco; 2004 Jun; 59(6):463-71. PubMed ID: 15178309
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
    Zhang YB, Feng LS, You XF, Guo Q, Guo HY, Liu ML.
    Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
    [Abstract] [Full Text] [Related]

  • 3. A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents.
    Al-Trawneh SA, El-Abadelah MM, Al-Abadleh MM, Zani F, Incerti M, Vicini P.
    Eur J Med Chem; 2014 Oct 30; 86():364-7. PubMed ID: 25180924
    [Abstract] [Full Text] [Related]

  • 4. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
    Vacher S, Pellegrin JL, Leblanc F, Fourche J, Maugein J.
    J Antimicrob Chemother; 1999 Nov 30; 44(5):647-52. PubMed ID: 10552981
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
    Wang JX, Zhang YB, Liu ML, Wang B, Chai Y, Li SJ, Guo HY.
    Eur J Med Chem; 2011 Jun 30; 46(6):2421-6. PubMed ID: 21481984
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A, Ghodsi S, Emami S, Najjari S, Samadi N, Faramarzi MA, Beikmohammadi L, Shirazi FH, Shafiee A.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3499-503. PubMed ID: 16644219
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines.
    Sato K, Tomioka H, Akaki T, Kawahara S.
    Int J Antimicrob Agents; 2000 Sep 01; 16(1):25-9. PubMed ID: 11185410
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y, Ohno H, Miyazaki Y, Higashiyama Y, Yanagihara K, Hirakata Y, Fukushima K, Kohno S.
    Antimicrob Agents Chemother; 2007 Nov 01; 51(11):4071-6. PubMed ID: 17709469
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
    Chai Y, Liu ML, Lv K, Feng LS, Li SJ, Sun LY, Wang S, Guo HY.
    Eur J Med Chem; 2011 Sep 01; 46(9):4267-73. PubMed ID: 21764484
    [Abstract] [Full Text] [Related]

  • 12. The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.
    Huang X, Chen D, Wu N, Zhang A, Jia Z, Li X.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4130-3. PubMed ID: 19539467
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, characterization and biological activity of a series of carboxamide derivatives of ofloxacin.
    Arayne MS, Sultana N, Haroon U, Zuberi MH, Rizvi SB.
    Arch Pharm Res; 2010 Dec 01; 33(12):1901-9. PubMed ID: 21191753
    [Abstract] [Full Text] [Related]

  • 15. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
    Tomioka H.
    Arch Immunol Ther Exp (Warsz); 2000 Dec 01; 48(3):183-8. PubMed ID: 10912623
    [Abstract] [Full Text] [Related]

  • 16. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M, Gutierrez J, Ruiz P, Moreno G.
    Chemotherapy; 1995 Dec 01; 41(3):204-7. PubMed ID: 7656667
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y, Wang J, Liu M, Yi H, Sun L, You X, Guo H.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3377-80. PubMed ID: 21515052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S, Tada A, Nagare H.
    Kekkaku; 2001 Apr 01; 76(4):357-62. PubMed ID: 11398326
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines.
    Dang Z, Yang Y, Ji R, Zhang S.
    Bioorg Med Chem Lett; 2007 Aug 15; 17(16):4523-6. PubMed ID: 17566733
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.